Genetic justification of severe COVID-19 using a rigorous algorithm

Eleni Gavriilaki1, Panagiotis G Asteris2, Tasoula Touloumenidou1

  • 1Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Insights

Genetic factors like ADAMTS13, C3, and CFH variants are linked to severe COVID-19 and ICU admission. Identifying these genetic susceptibilities may guide targeted treatments for high-risk patients.

Area of Science:

  • Immunogenetics
  • Infectious Diseases
  • Hematology

Background:

  • Severe COVID-19 (coronavirus disease 19) involves excessive complement system activation, similar to complement-mediated thrombotic microangiopathy (TMA).
  • Genetic predisposition may influence COVID-19 severity, mirroring patterns observed in TMA.

Purpose of the Study:

  • To investigate genetic susceptibility in severe COVID-19 patients.
  • To determine if genetic variants are associated with disease severity, specifically ICU hospitalization.

Main Methods:

  • Analysis of genetic and clinical data from 97 hospitalized COVID-19 patients.
  • Targeted next-generation sequencing to identify variants in ADAMTS13, C3, and complement factor H (CFH).

Main Results:

  • ADAMTS13 variants were found in 49 patients; C3 variants in 21, and CFH variants in 34.
  • A combination of these variants was independently associated with ICU hospitalization (p=0.022).
  • Specific combinations, like rs1042580 (thrombomodulin) with absence of rs800292 (CFH), correlated with no ICU need.

Conclusions:

  • Genetic variations in complement-related genes and ADAMTS13 are associated with severe COVID-19 and ICU admission.
  • This highlights a potential patient subgroup that could benefit from early complement inhibitor therapy.
  • Observed gender differences in variant distribution warrant further investigation.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.2K
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.3K
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview
76.7K
Genetic Variation01:25

Genetic Variation

Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
986
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
54.2K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.9K